stock_AMGN r_down	sector:1 has:1 highs:1 still:1 citing:1 record:1 near:1 likes:1 stocks:1 valuation:1 downgraded:1
stock_AMGN r_up	crash:1 help:1 avoid:1 landing:1 can:1 portfolio:1 2014:1 you:1 writes:1 recovery:1
stock_AMGN r_down	firm:1 transition:1 assist:1 remain:1 but:1 acting:1 names:1 until:1
stock_AMGN r_up	whose:1 watch:1 companies:1 shares:1 trade:1 active:1 see:1 session:1 expected:1 stocks:1
stock_AMGN r_down	fourth-quarter:3 outlook:1 30:2 revenue:1 cents:1 issued:1 reported:1 fall:1 share:2 sales:2 trade:1 earnings:3 session:3 businesses:1 dropped:1 saying:1 flight:1 swung:1 its:4 out:1 37:1 decline:1 actively:1 missed:1 topped:1 profit:2 surprises:1 quarterly:1 expectations:3 shares:3 latest:1 increase:1 advisories:1 growth:1 disclosed:1 premarket:1 expected:1 boost:1 price:1 authorization:1 stock:1 poor:1 4.5:1 extended:1 's:3 plans:1 run-up:1 weakness:1 company:2 after:1 buyback:1 volume:1 most:2 wiping:1 fell:1 operating:1 display-ad:1 preliminary:1 dividend:1 future:1 regular:1 $:2 billion:1 improved:1 largely:1 --:1 15:1 companies:2 cancellations:1 reports:1 5.8:1 below:1 weather:1 products:1 due:1 rose:1 quarters:1 led:1 corporate:1 roundup:1 solidly:1
stock_AMGN r_down	sector:1 reinvigorate:1 expect:1 have:1 year:1 follow:1 investment:1 gains:1 unusual:1 federal:1 pros:1 health:1 new:1 discovery:1 's:1 diseases:1 government:1 big:2 formed:1 diabetes:1 pact:1 like:1 medicines:1 companies:1 up:1 drug:1 more:1
stock_AMGN r_down	advisory:2 all:1 executive:1 entity:1 held:1 businesses:1 topped:1 year-earlier:1 its:3 $:3 immune:1 rose:1 investigational:1 treatment:1 has:1 2013:1 versus:1 division:1 collaborate:1 hit:1 combination:1 evaluate:1 continued:1 bank:2 drugmaker:1 loss:1 --:1 fully:1 including:1 quarter:1 system:1 body:1 financial:1 doing:1 related:1 year:1 81:1 investment:1 said:1 profit:1 current:1 new:1 therapies:1 cost-cutting:1 full:1 business:1 million:2 reported:1 restructuring:1 target:1 efforts:1 drugmakers:1 studies:1 experimental:1 first:2 fourth-quarter:2 cancer:2 owned:1 immunotherapy:1 61:1 another:1 management:2 basis:1 three:1 asset:1 entered:1 agreements:1 interests:1 billion:1 drugs:1 company:1 part:1 former:1 14:2 showed:1 cells:1 promising:1 revenues:1 weaker:1 outstanding:1 cents:4 share:3 sales:1 expenses:1 swung:1 conversion:1 strength:1 5.4:1 officers:1 40:1 1:1 also:1 other:1 5:1 earnings:3 's:6 separate:1 collaboration:1 unleash:1 confirmed:1 fell:1 midsize:1 class:1 ago:1 traditional:1 managing:1 directors:1 so:1 time:1
stock_AMGN r_up	says:1 immunotherapy:1 cancer:1 drugs:1 evaluate:1 collaboration:1 three:1 drug:1 its:1 class:1 investigational:1 part:1 agreements:1 promising:1 new:1 entered:1 maker:1 experimental:1 treatment:1
stock_AMGN r_down	they:1 related:1 watched:1 said:1 group:1 asks:1 negative:1 adverse:2 potential:1 conduct:1 has:1 cause:1 events:2 drugs:1 aware:1 closely:1 regulatory:1 cognitive:1 assessment:1 drug:1 cholesterol:1 become:1 anti-cholesterol:1 filing:1 experimental:1
stock_AMGN r_up	upper:1 primary:2 '':3 balanced:1 events:1 its:7 pharmaceutical:1 said:4 studying:2 generally:1 3:2 adverse:1 reduction:2 treatment:1 top-line:1 patients:1 ``:3 company:2 cholesterol:4 infection:1 results:1 met:2 were:1 groups:1 endpoint:2 rare:1 most:1 disease:1 drug:2 across:1 trial:3 bad:2 common:1 positive:1 serious:1
stock_AMGN r_down	learning:1 investors:1 hard:1 some:1 up:1 down:1 way:1 goes:1 lesson:1 stocks:1 come:1 must:1
stock_AMGN r_down	sector:1 biotech:1 good:1 look:1 once-hot:1 sign:1 ugly:1 which:1 not:1 broader:1 market:1
stock_AMGN r_up	pharmaceutical:1 off:1 help:1 ahead:1 people:1 companies:1 drug:1 insured:1 while:1 costs:1 holding:1 under:1 go:1 providing:1 other:1
stock_AMGN r_up	may:1 trials:1 require:1 drug:1 approving:1 prior:1 cholesterol:1 outcomes:1
stock_AMGN r_down	measuring:1 said:1 's:1 failed:1 survival:1 overall:1 trial:1 3:1 endpoint:1 treatment:1 meet:1 melanoma:1 its:1 secondary:1
stock_AMGN r_down	's:1 leaves:1 extends:1 chooses:1 contract:1
stock_AMGN r_down	biotech:1 selling:1 off:1 center:1 again:1 5.5:1 hard:1 down:1 tech:1 storm:1 stocks:1 than:1 market:1 more:1
stock_AMGN r_down	's:1 they:1 investors:1 markets:1 ride:1 been:1 hot:1 can:1 have:1 wild:1 chasing:1 teach:1 stocks:1 technology:1
stock_AMGN r_up	sector:1 help:1 empire:1 revenue:2 trade:1 down:1 see:1 growth:2 shares:1 have:1 's:2 allay:1 its:1 hit:1 25:3 said:1 mounting:1 been:1 should:1 pharmaceuticals:1 concerns:1 session:1 earnings:2 between:1 expected:1 higher:1 companyâ€™s:1 first-quarter:2 whose:1 company:1 rise:2 watch:1 return:1 fell:1 active:1 stocks:1 building:1 companies:1 deals:1 costs:3 mega-mergers:1 threat:1
stock_AMGN r_down	among:1 quarters:1 revenue:1 results:1 trade:1 actively:2 trading:1 reports:1 saying:1 its:1 prepare:1 surprises:1 expectations:1 shares:5 stuck:1 advisories:1 earnings:4 quarterly:2 disappoint:1 beating:1 red:1 evening:1 's:1 after:1 weak:1 expected:1 they:1 fall:1 climbing:1 stocks:1 roundup:1 both:1 handily:1 ahead:1 future:1 later:1 companies:2 slumps:1 while:1 session:1 were:1 release:1 climb:1 corporate:1 latest:1
stock_AMGN r_down	said:1 goal:1 efficacy:2 failed:1 reach:1 sclerosis:1 primary:1 drug:1 results:1 produced:1 trial:1 clinical:1 treat:1 mixed:1 analysis:1 its:2 secondary:1
stock_AMGN r_up	help:1 elderly:1 walk:1 '':1 scientist:1 pharmaceutical:1 make:1 range:1 much:1 genetically:1 discovery:1 ``:1 his:1 diseases:1 again:1 drugs:1 engineered:1 regular:1 using:1 1997:1 could:1 companies:1 twice:1 patients:1 muscle:2 rebuild:1
stock_AMGN r_up	seeing:1 succeeds:1 headwinds:1 year:1 statin:1 blockbuster:2 its:3 if:1 patent:1 political:1 two:1 least:1 2011:1 pill:1 get:1 bid:1 acquire:1 reprise:1 act:1 takeover:1 king:1 prospects:1 off:1 --:1 statins:1 could:1 drug:1 until:1 cholesterol:1 went:1
stock_AMGN r_up	do:1 help:1 puts:1 pay:1 mind:1 yield:1 n't:1 pad:1 can:1 you:1 stocks:1 trips:1 owning:1
stock_AMGN r_down	sees:1 bullishness:1 investing:1 warns:1 newsletters:1 bearish:1 against:1
stock_AMGN r_up	1.4:1 week:1 all:1 upper:1 almost:1 1.8:1 results:1 dose:2 including:1 higher:1 skin:1 2.7:1 makers:1 headaches:1 said:2 group:2 positive:1 least:1 improvement:1 adverse:1 3:1 potential:1 treatment:1 shows:1 psoriasis:1 primary:1 met:1 75:1 compared:1 effects:2 placebo:1 included:1 secondary:1 lower:1 12:1 study:1 infections:1 disease:1 drug:1 patients:2 endpoints:1 clear:2 plaque:1
stock_AMGN r_up	comment:1 revenue:1 results:1 related:1 trade:2 disappointing:1 session:2 deadline:1 dropped:1 file:1 need:1 accounting:1 miss:1 its:1 recognition:1 said:1 $:1 projected:1 shares:2 delay:1 premarket:1 quarterly:1 's:3 may:1 company:2 period:1 expected:2 revising:1 report:1 doubtful:1 12:1 14:1 policy:1 warned:1 companies:2 trading:1 actively:2 light:1 accounts:1 latest:1
stock_AMGN r_up	ago:1 stocks:1 gains:1 racked:1 big:1 up:1 has:1 decades:1 bought:1
stock_AMGN r_up	one-year:1 based:1 funds:1 results:1 blame:1 grants:1 not:1 hedge:1 stock:1
stock_AMGN r_up	booming:1 biotech:1 pipeline:1 20:1 drugs:1 price:1 giant:1 premium:1 's:1 justify:1 than:1 more:1
stock_AMGN r_up	top:1 picks:1 some:1 4:1 names:1
stock_AMGN r_up	product:1 ripe:1 analyst:1 stiff:1 up:1 medicines:1 pipeline:1 competition:1 one:1 facing:1 legacy:1 split:1 lagging:1 portfolio:1 price:1 stock:1
stock_AMGN r_up	named:3 industrial:2 financial:7 outstanding:2 proven:2 2nd:1 past:2 serving:2 names:3 years:4 accounting:2 its:5 '':2 27:2 sheet:1 chief:7 same:3 track:2 role:2 take:3 new:3 has:5 worked:2 leader:2 today:1 firm:1 ``:4 recently:2 finance:2 very:2 company:3 three:2 conglomerate:2 controller:2 said:2 suited:2 post:3 strong:3 respected:2 pipeline:1 success:2 effective:1 --:2 record:2 departs:3 future:2 officer:7 team:2 release:2 balance:1 corporate:2 partnerships:1
stock_AMGN r_up	illnesses:1 raised:1 family:1 revenue:1 doctors:1 one:1 used:1 through:1 investors:1 trust:1 proceeds:1 kidney:1 after:1 stands:1 use:1 said:1 4.1:1 cancer:1 would:1 8.8:1 initial:1 had:1 two:1 shares:1 its:2 other:1 according:1 candidates:2 which:1 clinical:1 net:1 has:2 public:1 therapies:1 9.3:1 development:1 million:2 's:1 offering:1 never:1 pricey:1 much:1 regulators:1 filed:1 regulatory:2 group:1 now:1 concerns:1 expand:1 $:2 loss:1 include:1 developing:1 bills:1 disease:1 drug:4 called:1 out:1 2013:1 owns:1 businessman:1 2012:2 studies:1 filing:2 research:1
stock_AMGN r_down	junk:1 work:1 's:1 bonds:1 alternatives:1 dividend-paying:1 some:1 ideas:1 viable:1 growth:1 dropped:1 have:1 desk:1 stocks:1 potential:1
stock_AMGN r_down	high-court:1 provided:1 's:2 string:1 investors:1 bag:1 lawsuit:1 companies:1 v.:1 against:1 have:1 ruling:1 joins:1 mixed:1 cases:1 investor:1 recent:1
stock_AMGN r_up	given:1 said:1 's:2 adults:1 designation:1 company:1 progressing:1 drug:1 rapidly:1 breakthrough:1 therapy:1 blood:1 new:1 has:1 bone:1 cancer:1
stock_AMGN r_up	outlook:2 process:1 tidbits:1 we:2 one:1 session:1 rising:1 looks:1 our:1 touch:1 seen:1 its:1 before:1 decline:2 busy:1 service:1 cup:1 menu:1 expectations:1 shares:2 campus:1 increase:1 hot:1 interested:1 earnings:1 folks:1 you:1 hope:1 mascots:1 persevere:1 ...:1 eyes:1 extended:1 business:1 shall:1 beat:1 why:1 after:1 upon:1 here:2 stay:1 quarterly:1 heat:1 edges:1 weeds:1 not:1 join:1 wilting:1 day:1 those:1 cool:1 shine:1 your:2 odds:1 official:1 well:1 overshadowed:1 us:2 morning:1 're:1 can:1 stimulation:1
stock_AMGN r_up	reveals:1 cancer:1 agreed:1 soon:1 trade:2 ended:1 session:2 been:1 option:1 said:1 end:1 merger:1 media:1 stake:2 shares:2 targeted:1 9.9:1 expected:2 has:1 collaboration:1 's:2 gains:2 may:1 jumps:1 after:2 jointly:1 not:1 therapy:1 report:1 develop:1 both:1 pursue:1 companies:3 actively:2 rallies:1
stock_AMGN r_down	pharmaceutical:1 said:1 's:1 like:1 deal:1 offer:1 company:1 share:1 prepared:1 good:1 itself:1 board:1 recommend:1 got:1 has:2 looks:1 latest:1
stock_AMGN r_up	said:1 showed:1 kidney:1 positive:1 study:1 disease:1 results:1 chronic:1 treatment:1 phase:1 its:1 experimental:1 secondary:1
stock_AMGN r_up	streak:1 past:1 keeping:1 over:1 30:1 alive:1 years:1 1:1 fund:1 9:1 stock:1
stock_AMGN r_up	billion:1 's:1 $:1 launch:1 continuing:1 had:1 sales:1 hepatitis:1 than:1 drug:1 historic:1 treatment:1 expected:1 new:1 its:1 second-quarter:1 more:1
stock_AMGN r_up	bets:1 says:1 analyst:1 sign:1 bearish:1 against:1 one:1 market:1 pile:1 historically:1 which:1 growing:1 stocks:1 options:1 worrisome:1
stock_AMGN r_up	all:1 global:1 results:2 trade:1 held:1 session:1 yes:1 its:6 25:1 fronts:1 busy:1 $:3 masses:1 expectations:1 second-quarter:2 premarket:1 might:1 resources:1 dayâ€™s:1 do:2 customers:1 get:1 beat:1 bid:1 rise:1 focus:1 matters:1 conquer:1 surprise:1 world:1 day:1 loss:1 like:1 facilities:1 drop:2 companies:1 pharma:1 doubled:1 stopped:1 cholesterol:1 quarter:1 everyone:2 aims:1 some:1 idea:1 actively:1 trading:2 pricing:1 our:1 special:1 out:1 said:2 profit:1 review:1 shares:2 forecast:1 're:1 tidbits:1 new:2 burned:1 announced:1 we:2 million:1 free:1 hours:1 reported:1 restructuring:2 lucrative:1 here:1 regulatory:1 strong:1 thank:1 shine:1 hasten:1 last:1 would:1 ahead:1 33:1 could:1 contract:1 keep:1 cheering:1 operating:1 efforts:1 first:1 among:1 revenue:1 feel:1 another:1 narrowed:1 guest:1 service:1 spending:1 night:1 two:1 their:1 much:1 way:1 expected:1 upbeat:1 more:2 buy:1 drugs:1 reduce:1 company:2 else:2 part:1 hear:1 signaling:1 survived:1 prescription:1 line:1 surged:1 than:1 12:1 15:1 anything:1 developing:1 hosting:1 us:1 appealing:1 growth:1 something:1 bearing:1 have:1 ...:1 uptick:1 wsj.com:1 expenses:1 states:1 middle:1 say:1 soars:1 drug:2 chat:2 close:1 plan:1 swung:1 saw:1 if:1 make:1 winners:1 declined:1 which:1 upside:1 you:4 several:1 soar:1 week:1 extended:1 's:2 plans:1 may:1 earnings:1 after:3 reach:1 workforce:1 most:1 fruit:1 user:1 cracking:1 messaging:1 soared:1 fiscal:1 short:1 well:1 so:1 time:1
stock_AMGN r_down	little:1 after:1 offered:1 changed:1 ended:1 fell:1 mixed:1 economy:1 500:1 view:1
